68 related articles for article (PubMed ID: 15703432)
1. Anti-interleukin-12 antibody for active Crohn's disease.
Orenstein R
N Engl J Med; 2005 Feb; 352(6):627-8; author reply 627-8. PubMed ID: 15703432
[No Abstract] [Full Text] [Related]
2. Cytokine-based therapies for Crohn's disease--new paradigms.
Cominelli F
N Engl J Med; 2004 Nov; 351(20):2045-8. PubMed ID: 15537904
[No Abstract] [Full Text] [Related]
3. Anti-interleukin-12 antibody for active Crohn's disease.
Mannon PJ; Fuss IJ; Mayer L; Elson CO; Sandborn WJ; Present D; Dolin B; Goodman N; Groden C; Hornung RL; Quezado M; Yang Z; Neurath MF; Salfeld J; Veldman GM; Schwertschlag U; Strober W;
N Engl J Med; 2004 Nov; 351(20):2069-79. PubMed ID: 15537905
[TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin-12 antibody for active Crohn's disease.
Kolls JK; Zhang Z
N Engl J Med; 2005 Feb; 352(6):627-8; author reply 627-8. PubMed ID: 15706644
[No Abstract] [Full Text] [Related]
5. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
6. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
Sorrentino D; Terrosu G; Vadalà S; Avellini C
Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
[No Abstract] [Full Text] [Related]
7. Biologic therapy in Crohn's disease.
Williams MD; Omran ML; Gordon GL
Mo Med; 2009; 106(5):356-60. PubMed ID: 19902717
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin-12 antibody treatment for Crohn disease: potential risk of invasive disease due to mycobacteria and salmonellae infection.
MacLennan C; Lammas DA; Kumararatne DS
Clin Infect Dis; 2005 May; 40(9):1381-2. PubMed ID: 15825052
[No Abstract] [Full Text] [Related]
9. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
10. [Anti-TNF therapy and Crohn's disease].
Peyrin-Biroulet L
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):478-81. PubMed ID: 18439777
[No Abstract] [Full Text] [Related]
11. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
[No Abstract] [Full Text] [Related]
12. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
13. The management of fistulizing oral Crohn's disease with infliximab.
Staines KS; Green R; Felix DH
J Oral Pathol Med; 2007 Aug; 36(7):444-6. PubMed ID: 17617840
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.
Nos P; Bastida G; Beltran B; Aguas M; Ponce J
Am J Gastroenterol; 2006 Sep; 101(9):2165-6. PubMed ID: 16968516
[No Abstract] [Full Text] [Related]
15. High risk of infectious disease caused by salmonellae and mycobacteria infections in patients with Crohn disease treated with anti-interleukin-12 antibody.
Fieschi C; Allez M; Casanova JL
Clin Infect Dis; 2005 May; 40(9):1381. PubMed ID: 15825051
[No Abstract] [Full Text] [Related]
16. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?
Fiocchi C
N Engl J Med; 2004 Feb; 350(9):934-6. PubMed ID: 14985492
[No Abstract] [Full Text] [Related]
17. [Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center].
Dotan I; Yeshurun D; Hallak A; Horowitz N; Tiomny E; Reif S; Halpern Z; Rachmilewitz D
Harefuah; 2001 Apr; 140(4):289-93, 368. PubMed ID: 11303390
[TBL] [Abstract][Full Text] [Related]
18. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
Ben Hriz F; Habbessi H; Maamouri N; Belkahla N; Ouerdiane S; Chouaib S; Ouerghi H; Chaabouni H; Ben Mami N
Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
[No Abstract] [Full Text] [Related]
20. Infliximab: new indication. Severe Crohn's disease in children: many unknowns.
Prescrire Int; 2008 Aug; 17(96):145. PubMed ID: 19489184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
